TD Cowen Reiterates Buy Rating on MBX Biosciences Inc (MBX): "confident" that canvu Phase III will be successful
Tweet Send to a Friend
TD Cowen analyst Tyler Van Buren reiterated a Buy rating on MBX Biosciences Inc (NASDAQ: MBX)The analyst commented, "MBX is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
